HBI Deals+Insights / News
Trump's executive order on dialysis has been deemed a good thing for Davita and Fresenius Medical Care by the analyst and industry community. But their share prices have barely rebounded to their pre-announcement level at the time of writing, potentially indicating there is still some market wariness over what it means for them.





